Castle’s DecisionDx-SCC Test Significantly Improves Prediction Accuracy of Metastatic Events After Mohs Surgery in Patients With High-Risk SCC of the Head and Neck May 3, 2024
DART: Medicare Administrative Contractor’s Coverage Proposal on IGSRT Will Jeopardize Progress, Patient Outcomes May 2, 2024
Apply Now: The Canadian Dermatology Association’s 2024 Shade Structure Grant Application Program Is Open May 2, 2024
There’s Something About Eblasakimab: Aslan, Zenyaku Partner to Investigate How it Differs From Other Biologics for AD May 2, 2024